SCHEMBL13035488

SCHEMBL13035488

COC(=O)[C@H](COc1cccc(C=O)c1B1OC(C)(C)C(C)(C)O1)NC(=O)OC(C)(C)C

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AAK1 Q2M2I8 2/20 0.39
EPHX2 P34913 3/20 0.39
PPARA Q07869 2/20 0.35
KLK5 Q9Y337 2/20 0.35
KLK7 P49862 1/20 0.35
CTSS P25774 1/20 0.34
CTSK P43235 1/20 0.34
CACNA1B Q00975 1/20 0.34
TACR1 P25103 1/20 0.34
KDM4E B2RXH2 2/20 0.33
ALDH1A1 P00352 2/20 0.33
GSTP1 P09211 1/20 0.33
GSTM2 P28161 1/20 0.33
MAPT P10636 1/20 0.33
PPARG P37231 1/20 0.33
NFKB1 P19838 1/20 0.33
NFKB2 Q00653 1/20 0.33
RELA Q04206 1/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3446176 0.91 EPHX2 (0.39) AAK1EPHX2KLK5KLK7CTSS
SCHEMBL13035456 0.82 AAK1 (0.41) AAK1EPHX2KDM4E
SCHEMBL16706953 0.81 TLR2 (0.34) AAK1KDM4EALDH1A1MAPTMEN1
SCHEMBL13035491 0.81 KLK5 (0.41) AAK1EPHX2PPARAKLK5CTSS
SCHEMBL462451 0.79 CA12 (0.41) AAK1KDM4E
SCHEMBL15077416 0.76 ALDH1A1 (0.35) AAK1ALDH1A1
SCHEMBL15078733 0.75 LMNA (0.36) KDM4EALDH1A1KMT2A
SCHEMBL13035468 0.75 ALDH1A1 (0.46) KDM4EALDH1A1MAPTNFKB1NFKB2
SCHEMBL15077401 0.74 SMN1; SMN2 (0.33) KDM4EALDH1A1
SCHEMBL15077383 0.74 SMN1; SMN2 (0.33) KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8895534-B2 Boron containing small molecules ANACOR PHARMACEUTICALS, INC. (US) 2014-11-25 US disclosed
US-20100292504-A1 BORON-CONTAINING SMALL MOLECULES ANACOR PHARMACEUTICALS, INC. (US) 2010-11-18 US disclosed
US-7816344-B2 oxaboroles such as 3-[[(3S)-3-(aminomethyl)-1-hydroxy-3H-2,1-benzoxaborol-7-yl]oxy]propan-1-ol, useful for treating bacterial infections; microbiocides; antibiotics ANACOR PHARMACEUTICALS, INC. (US) 2010-10-19 US disclosed
US-7816344-B2 oxaboroles such as 3-[[(3S)-3-(aminomethyl)-1-hydroxy-3H-2,1-benzoxaborol-7-yl]oxy]propan-1-ol, useful for treating bacterial infections; microbiocides; antibiotics ANACOR PHARMACEUTICALS, INC. (US) 2010-10-19 US disclosed
US-20090227541-A1 oxaboroles such as 3-[[(3S)-3-(aminomethyl)-1-hydroxy-3H-2,1-benzoxaborol-7-yl]oxy]propan-1-ol, useful for treating bacterial infections; microbiocides; antibiotics ANACOR PHARMACEUTICALS, INC. (US) 2009-09-10 US disclosed
US-20090227541-A1 oxaboroles such as 3-[[(3S)-3-(aminomethyl)-1-hydroxy-3H-2,1-benzoxaborol-7-yl]oxy]propan-1-ol, useful for treating bacterial infections; microbiocides; antibiotics ANACOR PHARMACEUTICALS, INC. (US) 2009-09-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100292504-A1 BORON-CONTAINING SMALL MOLECULES BCL6B, BLVRB, BCL6 AAK1 3349/4885EPHX2 4401/4885PPARA 3933/4885
US-20090227541-A1 oxaboroles such as 3-[[(3S)-3-(aminomethyl)-1-hydroxy-3H-2,1-benzoxaborol-7-yl]oxy]propan-1-ol, useful for treating bacterial infections; microbiocides; antibiotics OXA1L, TLR1, OXER1 AAK1 2461/4885EPHX2 1700/4885PPARA 202/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.